SLXN
Silexion Therapeutics Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.61
-0.06 ▼ -3.68%
🌙 3월 13일 7:08 PM ET (한국 3/14 08:08)
$1.60
+0.00 -0.21%
| Index | - | P/E | - | EPS (ttm) | -25.21 | Insider Own | 23.39% | Shs Outstand | 0.00B | Perf Week | -7.23% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 36.37% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -2.73% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -1.12 | Inst Own | 7.84% | Short Float | 1.78% | Perf Quarter | -46.85% |
| Income | -0.01B | P/S | - | EPS this Y | 98.47% | Inst Trans | 6.53% | Short Ratio | 1.09 | Perf Half Y | -67.44% |
| Sales | 0.00B | P/B | 0.72 | EPS next 5Y | 80.36% | ROA | -125.8% | Short Interest | 0.05M | Perf YTD | -16.41% |
| Book/sh | 2.23 | P/C | 0.58 | EPS past 3/5Y | -286.21% -286.09% | ROE | -771.23% | 52W High | -92.82% ($22.36) | Perf Year | -91.64% |
| Cash/sh | 2.78 | P/FCF | - | Sales past 3/5Y | - | ROIC | -104.75% | 52W Low | 13.03% ($1.42) | Perf 3Y | -99.88% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 91.47% | Gross Margin | - | Volatility(W/M) | 12.29% 8.09% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.16 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.97 | EPS Q/Q | 98.95% | Profit Margin | - | RSI (14) | 42.8 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.97 | Sales Q/Q | - | SMA20 | -3.8% ($1.67) | Beta | -0.05 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.29 | Earnings | 11000000 | SMA50 | -13.25% ($1.86) | Rel Volume | 0.65 | Prev Close | $1.67 |
| Employees | 14 | LT Debt/Eq | 0.27 | EPS/Sales Surpr. | 15.29% - | SMA200 | -71.34% ($5.62) | Avg Volume(3M) | 0.04M | Price | $1.61 |
| IPO | 2021/4/7 | Option/Short | No/Yes | Trades | 180 | Volume | 27,170 | Change | -3.68% |
뉴스 로딩 중...